Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics

Abstract Background The progression of bladder cancer (BC) from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) significantly increases disease severity. Although the tumor microenvironment (TME) plays a pivotal role in this process, the heterogeneity of tumor cel...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianpeng Li, Yunzhong Jiang, Minghai Ma, Lu Wang, Minxuan Jing, Zezhong Yang, Mengzhao Zhang, Ke Chen, Jinhai Fan
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06138-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571341056770048
author Jianpeng Li
Yunzhong Jiang
Minghai Ma
Lu Wang
Minxuan Jing
Zezhong Yang
Mengzhao Zhang
Ke Chen
Jinhai Fan
author_facet Jianpeng Li
Yunzhong Jiang
Minghai Ma
Lu Wang
Minxuan Jing
Zezhong Yang
Mengzhao Zhang
Ke Chen
Jinhai Fan
author_sort Jianpeng Li
collection DOAJ
description Abstract Background The progression of bladder cancer (BC) from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) significantly increases disease severity. Although the tumor microenvironment (TME) plays a pivotal role in this process, the heterogeneity of tumor cells and TME components remains underexplored. Methods We characterized the transcriptomes of single cells from 11 BC samples, including 4 NMIBC, 4 MIBC, and 3 adjacent normal tissues. Bulk RNA-seq data were used to validate the clinical features of characteristic cells, and protein levels of these cells were further confirmed through immunohistochemistry (IHC) and multiplex immunofluorescence. Results Bladder cancer progression was associated with distinct transcriptomic features in the TME. Tumor cells in MIBC displayed enhanced glycolytic activity and downregulation of chemokines and MHC-II molecules, reducing immune cell recruitment and facilitating immune evasion. This highlights glycolysis as a potential therapeutic target for disrupting tumor progression. We identified a T cell exhaustion pathway from naive CD8 + T cells (CD8 + TCF7) to terminally exhausted CD8 + STMN1 cells, with progressively declining immune surveillance. Targeting intermediate exhaustion states may restore T cell function and improve anti-tumor immunity. Macrophages polarized toward a pro-tumorigenic phenotype, while VEGFA + mast cells promoted angiogenesis in early-stage BC, suggesting their role as potential targets for therapeutic intervention in NMIBC. Furthermore, conventional dendritic cells (DCs) transformed into LAMP3 + DCs, contributing to an immunosuppressive microenvironment and enabling immune evasion. Conclusion This study reveals dynamic changes in the TME during BC progression, including enhanced glycolysis, T cell exhaustion, and immune cell remodeling, which contribute to immune evasion and tumor progression. These findings identify critical pathways and cell populations as potential therapeutic targets, offering new strategies to improve treatment outcomes in BC patients.
format Article
id doaj-art-e53220b7d01e4be393d81ace8877e688
institution Kabale University
issn 1479-5876
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-e53220b7d01e4be393d81ace8877e6882025-02-02T12:40:37ZengBMCJournal of Translational Medicine1479-58762025-01-0123112210.1186/s12967-025-06138-6Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomicsJianpeng Li0Yunzhong Jiang1Minghai Ma2Lu Wang3Minxuan Jing4Zezhong Yang5Mengzhao Zhang6Ke Chen7Jinhai Fan8Department of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Vascular Surgery, First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, First Affiliated Hospital of Xi’an Jiaotong UniversityAbstract Background The progression of bladder cancer (BC) from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) significantly increases disease severity. Although the tumor microenvironment (TME) plays a pivotal role in this process, the heterogeneity of tumor cells and TME components remains underexplored. Methods We characterized the transcriptomes of single cells from 11 BC samples, including 4 NMIBC, 4 MIBC, and 3 adjacent normal tissues. Bulk RNA-seq data were used to validate the clinical features of characteristic cells, and protein levels of these cells were further confirmed through immunohistochemistry (IHC) and multiplex immunofluorescence. Results Bladder cancer progression was associated with distinct transcriptomic features in the TME. Tumor cells in MIBC displayed enhanced glycolytic activity and downregulation of chemokines and MHC-II molecules, reducing immune cell recruitment and facilitating immune evasion. This highlights glycolysis as a potential therapeutic target for disrupting tumor progression. We identified a T cell exhaustion pathway from naive CD8 + T cells (CD8 + TCF7) to terminally exhausted CD8 + STMN1 cells, with progressively declining immune surveillance. Targeting intermediate exhaustion states may restore T cell function and improve anti-tumor immunity. Macrophages polarized toward a pro-tumorigenic phenotype, while VEGFA + mast cells promoted angiogenesis in early-stage BC, suggesting their role as potential targets for therapeutic intervention in NMIBC. Furthermore, conventional dendritic cells (DCs) transformed into LAMP3 + DCs, contributing to an immunosuppressive microenvironment and enabling immune evasion. Conclusion This study reveals dynamic changes in the TME during BC progression, including enhanced glycolysis, T cell exhaustion, and immune cell remodeling, which contribute to immune evasion and tumor progression. These findings identify critical pathways and cell populations as potential therapeutic targets, offering new strategies to improve treatment outcomes in BC patients.https://doi.org/10.1186/s12967-025-06138-6TMEMIBCNMIBCScRNA-seqT cellEpithelial cell
spellingShingle Jianpeng Li
Yunzhong Jiang
Minghai Ma
Lu Wang
Minxuan Jing
Zezhong Yang
Mengzhao Zhang
Ke Chen
Jinhai Fan
Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
Journal of Translational Medicine
TME
MIBC
NMIBC
ScRNA-seq
T cell
Epithelial cell
title Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
title_full Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
title_fullStr Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
title_full_unstemmed Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
title_short Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
title_sort epithelial cell diversity and immune remodeling in bladder cancer progression insights from single cell transcriptomics
topic TME
MIBC
NMIBC
ScRNA-seq
T cell
Epithelial cell
url https://doi.org/10.1186/s12967-025-06138-6
work_keys_str_mv AT jianpengli epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT yunzhongjiang epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT minghaima epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT luwang epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT minxuanjing epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT zezhongyang epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT mengzhaozhang epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT kechen epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics
AT jinhaifan epithelialcelldiversityandimmuneremodelinginbladdercancerprogressioninsightsfromsinglecelltranscriptomics